August 22, 2022
Shionogi/Roche’s anti-flu drug Xofluza (baloxavir marboxil) has won US FDA approval for an additional indication for the treatment of children aged five years and older. The drug was approved for “the treatment of acute uncomplicated influenza in otherwise healthy children...read more